Phibro Animal Health (PAHC) Invested Capital (2013 - 2026)

Phibro Animal Health's Invested Capital history runs 14 years deep, the most recent figure standing at $22.8 million for Q1 2026.

• On a quarterly basis, Invested Capital rose 40.5% year-over-year to $22.8 million in Q1 2026; TTM through Mar 2026 was $78.2 million, a 11.99% increase from a year earlier, with the FY2025 full-year figure at $16.2 million, down 45.46% from the prior year.
• Invested Capital grew to $22.8 million in Q1 2026 per PAHC's latest filing, from $20.6 million in the prior quarter.
• Across five years, Invested Capital topped out at $29.8 million in Q1 2024 and bottomed at $7.5 million in Q3 2024.
• The 5-year median for Invested Capital is $17.3 million (2024), against an average of $19.5 million.
• Across the five-year window, Invested Capital surged 218.6% in 2022 and plunged 68.94% in 2024, its largest moves.
• Year by year, Invested Capital stood at $15.4 million in 2022, then surged by 68.9% to $26.0 million in 2023, then sank by 37.61% to $16.2 million in 2024, then gained by 27.0% to $20.6 million in 2025, then advanced by 10.63% to $22.8 million in 2026.
• Per Business Quant, the three latest PAHC Invested Capital figures stand at $22.8 million (Q1 2026), $20.6 million (Q4 2025), and $18.4 million (Q3 2025).